Mordechai Boehm
👏 Combigene has exceeded my expectations. Their services are excellent and the team is highly professional. I am satisfied with their work and would recommend them without any hesitation.
Kevin Reyes
I recently worked with this company and I am impressed. They deliver high-quality results and have a professional approach towards their work. I would definitely recommend them to others.
Jennifer Rampe
My experience with Combigene has been amazing. They provide top-notch services and their team is very knowledgeable. I am impressed with their expertise and would definitely work with them again.
Billy Anderson
I have been a customer of Combigene for a while now, and I must say they have exceeded my expectations. The team is knowledgeable and provides great solutions for my business needs. I highly recommend their services.
Tracy Miller
I have had a great experience with Combigene. They provide excellent services and their website is very user-friendly. The team is highly professional and responsive. I would definitely recommend Combigene to anyone looking for a reliable company.
Brittany Hathorn
Combigene is 👍. Their services are excellent and the team is very helpful. I had a few questions and they promptly answered all of them. I am happy with their service and would definitely recommend them.
Dale Bodwell
Their services are top-notch. I really liked the way they handled my project. The team was efficient and delivered the results on time. I am satisfied with their work and would consider working with them again.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Combigene
CombiGene provides patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. CombiGene is developing a breakthrough therapy with the potential to dramatically improve the quality of life for a group of epilepsy patients for whom there is currently no effective treatment. CombiGene uses an adeno-associated viral vector (AAV) to administer a combination of neuropeptide Y (NPY) and its receptor Y2 directly to the part of the brain where the epileptic seizure begins. The most important preclinical effect studies have been concluded with positive results and the next step will be the compulsory safety studies. Given a positive outcome from the safety studies and successful GMP production of CG01, studies in humans can begin.
- Website
- combigene.com
- Categories
- Biotechnology